Detected ·
Opal Therapeutics
$1.25M—
Opal Therapeutics (Techstars 2024), a biotech focused on women's gynecological health, has raised $1.25M through an NSF SBIR Phase II award to scale its 'uterus in a dish' organoid platform for drug discovery.
- Website
- www.opaltherapeutics.com
- Amount
- $1 250 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-09 20:01:47 UTC
- Signal ID
- 64d04e7d-23e3-4759-a39a-2843e9df745d
As the API returns it
{
"id": "64d04e7d-23e3-4759-a39a-2843e9df745d",
"created_at": "2026-08-09T20:01:47.058934Z",
"company_name": "Opal Therapeutics",
"company_website_url": "www.opaltherapeutics.com",
"company_linkedin_url": "https://www.linkedin.com/company/opal-therapeutics",
"event_type": "funding",
"funding_amount": 1250000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Opal Therapeutics (Techstars 2024), a biotech focused on women's gynecological health, has raised $1.25M through an NSF SBIR Phase II award to scale its 'uterus in a dish' organoid platform for drug discovery.*"
}